Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.
Dr. Sandip Patel
Advertisement
Patel is a professor of Medical Oncology at University of California, San Diego (UCSD). He also serves as the leader of Experimental Therapeutics, deputy director of the Sanford Stem Cell Clinical Center, co-leader of Solid Tumor Therapeutics, and medical director of Clinical Research Informatics.
Articles by Dr. Sandip Patel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Every FDA Oncology Approval From November 2025
2
Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds
3
Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital
4
Fixed Duration Venclexta Combos Delay Progression in CLL Similarly to Imbruvica
5
